Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
09/10/2026 13:10
BRIEF-Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026 Oct 9 (Reuters) - Quince Therapeutics, Inc. QNCX.O:
QUINCE THERAPEUTICS - APPOINTS BRIGETTE ROBERTS AS CEO EFFECTIVE OCTOBER 8, 2026 - SEC FILING
Source text: [ID:n0001193125-26-418538]
Further company coverage: QNCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges